AS and axSpA now have multiple approved biologics, but newer agents are in trials. Here's what's recruiting and who qualifies.
About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.
What You Need to Know
A guide to ankylosing spondylitis (AS) and axial spondyloarthritis (axSpA) clinical trials in 2025 — IL-17 inhibitors, JAK inhibitors, and nr-axSpA studies.
Find recruiting trials for your condition
Search ClinicalTrials.gov in real time — matched to your profile, explained in plain English. Free, no account required.
Start Free Search →How Tidera Health Can Help
Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.
Enter your condition and location to see currently recruiting trials matched to your profile — with plain-English eligibility explanations and questions to ask the research coordinator.